Abstract: The invention relates to a non-invasive, prenatal, in-vitro method for detecting the normal healthy condition, the condition of a healthy carrier or the condition of a carrier inflicted with cystic fibrosis, from the fetal cell(s) from a maternal sample, comprising the DNA of an individual to be tested. The invention also relates to oligonucleotide primers and to their use within the scope of a non-invasive, prenatal, in-vitro method for detecting the condition of a healthy carrier or of a carrier inflicted with cystic fibrosis.
Type:
Application
Filed:
January 18, 2006
Publication date:
December 24, 2009
Applicants:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), ASSISTANCE PUBLIC-HOPITAUX DE PARIS, UNIVERSITE RENE DESCARTES PARIS V
Inventors:
Patrizia Paterlini, Jean-Paul Bonnefont, Isabelle Desitter, Ali Saker